Zydus Lifesciences sets AGM on Aug 11, record date July 24
Zydus Lifesciences Limited has announced the 31st Annual General Meeting for August 11, 2026, to be held via video conferencing. Remote e-voting is available from August 8 to August 10, 2026. The record date for determining dividend entitlement for the financial year ended March 31, 2026, is fixed as July 24, 2026.

*this image is generated using AI for illustrative purposes only.
Zydus Lifesciences Limited has scheduled its 31st Annual General Meeting for August 11, 2026, at 10:00 a.m. IST via Video Conferencing. The meeting will transact business through electronic voting only, with remote e-voting commencing on August 8, 2026, and concluding on August 10, 2026. The record date to determine member entitlement for the dividend for the financial year ended March 31, 2026, is Friday, July 24, 2026.
E-Voting and Shareholder Participation
The company has appointed Mr. Ashish Doshi, Practicing Company Secretary, as the Scrutinizer to ensure the fair conduct of remote e-voting and e-voting during the AGM. Shareholders holding shares in physical or dematerialized mode as of the cut-off date, Tuesday, August 4, 2026, are eligible to vote. Members who have cast their vote via remote e-voting may participate in the AGM through VC/OAVM but are not entitled to vote again during the meeting.
Corporate Calendar
| Event | Date |
|---|---|
| 31st Annual General Meeting | August 11, 2026 |
| Remote E-Voting Start | August 8, 2026, 9:00 a.m. IST |
| Remote E-Voting End | August 10, 2026, 5:00 p.m. IST |
| Record Date for Dividend | July 24, 2026 |
| Cut-off Date for Voting | August 4, 2026 |
The Integrated Annual Report for FY2025-26 was sent electronically to members on July 10, 2026. Shareholders holding physical shares are requested to update their KYC details and email addresses with the Registrar and Share Transfer Agent to ensure seamless communication and dividend receipt.
Historical Stock Returns for Zydus Life Science
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.71% | +4.64% | +4.09% | +28.60% | +17.61% | +79.67% |
What key agenda items are expected to be discussed during the 31st AGM that could influence Zydus Lifesciences' strategic direction?
How might the dividend announcement impact investor sentiment and stock performance leading up to the record date?
What are the anticipated trends in shareholder participation given the continued reliance on e-voting and virtual meetings?































